Marvel Biosciences Corp. — Proxy Solicitation & Information Statement 2024

Dec 18, 2024

December 18, 2024

ODYSSEY

Filed via SEDAR+

To All Applicable Exchanges and Securities Administrators

Subject: Marvel Biosciences Corp. (the "Issuer")
Notice of Meeting and Record Date

Dear Sir/Madam:

We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:

Meeting Type:	Annual General Special Meeting
Meeting Date:	January 15, 2025
Record Date for Notice of Meeting:	December 16, 2024
Record Date for Voting (if applicable):	December 16, 2024
Beneficial Ownership Determination Date:	December 16, 2024
Class of Securities Entitled to Vote:	Common Class
ISIN:	CA57384M1077
Issuer sending proxy materials directly to NOBOs:	No
Issuer paying for delivery to OBOs:	No
Notice and Access for Beneficial Holders:	No
Notice and Access for Registered Holders:	No

In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.

Yours truly,

Odyssey Trust Company
as agent for Marvel Biosciences Corp.